Cargando…

STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation

Lipid metabolism, especially fatty acid oxidation (FAO) dysfunction, is a major driver of renal fibrosis; however, the detailed regulatory mechanisms involved remain unclear. In this study, we showed that there existed an association between the signal transducer and activator of transcription 6 (ST...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianzhong, Yang, Youjing, Li, Qianmin, Wei, Shuhui, Zhou, Yujia, Yu, Wangjianfei, Xue, Lian, Zhou, Ling, Shen, Lei, Lu, Guoyuan, Chen, Ling, Tao, Shasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770798/
https://www.ncbi.nlm.nih.gov/pubmed/35046382
http://dx.doi.org/10.1038/s41419-022-04515-3
_version_ 1784635446632906752
author Li, Jianzhong
Yang, Youjing
Li, Qianmin
Wei, Shuhui
Zhou, Yujia
Yu, Wangjianfei
Xue, Lian
Zhou, Ling
Shen, Lei
Lu, Guoyuan
Chen, Ling
Tao, Shasha
author_facet Li, Jianzhong
Yang, Youjing
Li, Qianmin
Wei, Shuhui
Zhou, Yujia
Yu, Wangjianfei
Xue, Lian
Zhou, Ling
Shen, Lei
Lu, Guoyuan
Chen, Ling
Tao, Shasha
author_sort Li, Jianzhong
collection PubMed
description Lipid metabolism, especially fatty acid oxidation (FAO) dysfunction, is a major driver of renal fibrosis; however, the detailed regulatory mechanisms involved remain unclear. In this study, we showed that there existed an association between the signal transducer and activator of transcription 6 (STAT6) and tubular lipid metabolism in fibrotic kidneys. Specifically, STAT6 was activated along with the accumulation of lipids via the downregulation of FAO-related genes when mice were subjected to unilateral ureteral obstruction (UUO) or high-fat diet challenge. Tubular-specific depletion, or pharmacologic inhibitor of Stat6 in mice, and Stat6 knockdown in cultured tubular cells attenuated lipid accumulation and renal fibrosis by enhancing FAO. Mechanistically, STAT6 transcriptionally inhibited the expression of PPARα and its FAO-related target genes through a sis-inducible element located in the promoter region of the protein. In conclusion, our study demonstrates the mechanistic details of STAT6-mediated FAO dysregulation in the progression of renal fibrosis and provides a preclinical rationale for efforts to improve the management of renal fibrosis brought about by FAO dysregulation.
format Online
Article
Text
id pubmed-8770798
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87707982022-02-04 STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation Li, Jianzhong Yang, Youjing Li, Qianmin Wei, Shuhui Zhou, Yujia Yu, Wangjianfei Xue, Lian Zhou, Ling Shen, Lei Lu, Guoyuan Chen, Ling Tao, Shasha Cell Death Dis Article Lipid metabolism, especially fatty acid oxidation (FAO) dysfunction, is a major driver of renal fibrosis; however, the detailed regulatory mechanisms involved remain unclear. In this study, we showed that there existed an association between the signal transducer and activator of transcription 6 (STAT6) and tubular lipid metabolism in fibrotic kidneys. Specifically, STAT6 was activated along with the accumulation of lipids via the downregulation of FAO-related genes when mice were subjected to unilateral ureteral obstruction (UUO) or high-fat diet challenge. Tubular-specific depletion, or pharmacologic inhibitor of Stat6 in mice, and Stat6 knockdown in cultured tubular cells attenuated lipid accumulation and renal fibrosis by enhancing FAO. Mechanistically, STAT6 transcriptionally inhibited the expression of PPARα and its FAO-related target genes through a sis-inducible element located in the promoter region of the protein. In conclusion, our study demonstrates the mechanistic details of STAT6-mediated FAO dysregulation in the progression of renal fibrosis and provides a preclinical rationale for efforts to improve the management of renal fibrosis brought about by FAO dysregulation. Nature Publishing Group UK 2022-01-19 /pmc/articles/PMC8770798/ /pubmed/35046382 http://dx.doi.org/10.1038/s41419-022-04515-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Li, Jianzhong
Yang, Youjing
Li, Qianmin
Wei, Shuhui
Zhou, Yujia
Yu, Wangjianfei
Xue, Lian
Zhou, Ling
Shen, Lei
Lu, Guoyuan
Chen, Ling
Tao, Shasha
STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation
title STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation
title_full STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation
title_fullStr STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation
title_full_unstemmed STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation
title_short STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation
title_sort stat6 contributes to renal fibrosis by modulating pparα-mediated tubular fatty acid oxidation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770798/
https://www.ncbi.nlm.nih.gov/pubmed/35046382
http://dx.doi.org/10.1038/s41419-022-04515-3
work_keys_str_mv AT lijianzhong stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT yangyoujing stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT liqianmin stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT weishuhui stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT zhouyujia stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT yuwangjianfei stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT xuelian stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT zhouling stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT shenlei stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT luguoyuan stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT chenling stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation
AT taoshasha stat6contributestorenalfibrosisbymodulatingpparamediatedtubularfattyacidoxidation